CSL Limited (OTCMKTS:CSLLY) Short Interest Down 27.0% in August

CSL Limited (OTCMKTS:CSLLY) saw a large decline in short interest in August. As of August 15th, there was short interest totalling 2,700 shares, a decline of 27.0% from the July 31st total of 3,700 shares. Based on an average daily volume of 42,600 shares, the days-to-cover ratio is presently 0.1 days.

CSL Price Performance

Shares of OTCMKTS CSLLY traded down $1.01 during trading on Friday, hitting $104.28. 19,235 shares of the company were exchanged, compared to its average volume of 31,597. The firm’s fifty day moving average price is $101.52 and its 200 day moving average price is $95.72. CSL has a 1 year low of $71.51 and a 1 year high of $109.00.

Analyst Upgrades and Downgrades

Separately, Macquarie upgraded CSL to a “strong-buy” rating in a research note on Tuesday, August 13th.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.